- Home
- Publications
- Publication Search
- Publication Details
Title
CA125 and Ovarian Cancer: A Comprehensive Review
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 12, Pages 3730
Publisher
MDPI AG
Online
2020-12-14
DOI
10.3390/cancers12123730
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ovarian cancer: screening and future directions
- (2019) Keshav Kumar Gupta et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review
- (2019) Vincent Dochez et al. Journal of Ovarian Research
- Early stage detection and screening of ovarian cancer: a research opportunity and significant challenge for biosensor technology
- (2019) Brian De La Franier et al. BIOSENSORS & BIOELECTRONICS
- Epithelial ovarian cancer: Evolution of management in the era of precision medicine
- (2019) Stephanie Lheureux et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Diagnosis of epithelial ovarian cancer using a combined protein biomarker panel
- (2019) Matthew R. Russell et al. BRITISH JOURNAL OF CANCER
- Ovarian cancer statistics, 2018
- (2018) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Comparison of longitudinal CA125 algorithms as a first line screen for ovarian cancer in the general population
- (2018) Oleg Blyuss et al. CLINICAL CANCER RESEARCH
- Significance of Serum Human Epididymis Protein 4 and Cancer Antigen 125 in Distinguishing Type I and Type II Epithelial Ovarian Cancers
- (2018) Marut Yanaranop et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Screening for Ovarian Cancer
- (2018) Jillian T. Henderson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Sensitive on-chip detection of cancer antigen 125 using a DNA aptamer/carbon nanotube network platform
- (2018) Vinayakumar Gedi et al. SENSORS AND ACTUATORS B-CHEMICAL
- Noninvasive ovarian cancer biomarker detection via an optical nanosensor implant
- (2018) Ryan M. Williams et al. Science Advances
- Chronic Medical Conditions and CA125 levels among Women without Ovarian Cancer
- (2018) Babatunde O. Akinwunmi et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
- (2018) J. Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Outcomes from ovarian cancer screening in the PLCO trial: Histologic heterogeneity impacts detection, overdiagnosis and survival
- (2017) Sarah M. Temkin et al. EUROPEAN JOURNAL OF CANCER
- CT and MRI findings of type I and type II epithelial ovarian cancer
- (2017) Dong Liu et al. EUROPEAN JOURNAL OF RADIOLOGY
- Optimizing treatment in recurrent epithelial ovarian cancer
- (2017) Giacomo Corrado et al. Expert Review of Anticancer Therapy
- Impact of Recurrence of Ovarian Cancer on Quality of Life and Outlook for the Future
- (2017) Nicoletta Colombo et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Smartphone-based immunosensor for CA125 detection
- (2017) Oana Hosu et al. TALANTA
- Serum CA125 is a predictive marker for breast cancer outcomes and correlates with molecular subtypes
- (2017) Cheng Fang et al. Oncotarget
- The effect of CA125 on metastasis of ovarian cancer: old marker new function
- (2017) Qin Yuan et al. Oncotarget
- The Dualistic Model of Ovarian Carcinogenesis
- (2016) Robert J. Kurman et al. AMERICAN JOURNAL OF PATHOLOGY
- Ovarian Cancer, the Revised FIGO Staging System, and the Role of Imaging
- (2016) Sanaz Javadi et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- BRCA somatic mutations and epigenetic BRCA modifications in serous ovarian cancer
- (2016) M. Moschetta et al. ANNALS OF ONCOLOGY
- Diagnostic accuracy of cancer antigen 125 for endometriosis: a systematic review and meta-analysis
- (2016) M Hirsch et al. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
- Modification of cut-off values for HE4, CA125 and the ROMA algorithm for early-stage epithelial ovarian cancer detection: Results from 1021 cases in South China
- (2016) Ying Xu et al. CLINICAL BIOCHEMISTRY
- Extended mortality results for ovarian cancer screening in the PLCO trial with median 15 years follow-up
- (2016) Paul F. Pinsky et al. GYNECOLOGIC ONCOLOGY
- NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017
- (2016) Mary B. Daly et al. Journal of the National Comprehensive Cancer Network
- Ovarian Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology
- (2016) Robert J. Morgan et al. Journal of the National Comprehensive Cancer Network
- A microfluidic ExoSearch chip for multiplexed exosome detection towards blood-based ovarian cancer diagnosis
- (2016) Zheng Zhao et al. LAB ON A CHIP
- Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
- (2016) Ian J Jacobs et al. LANCET
- Can advanced-stage ovarian cancer be cured?
- (2016) Steven Narod Nature Reviews Clinical Oncology
- Practice Bulletin No. 174 Summary
- (2016) OBSTETRICS AND GYNECOLOGY
- Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated burden
- (2016) Liang Liu et al. Oncotarget
- Integrated Microfluidic Lectin Barcode Platform for High-Performance Focused Glycomic Profiling
- (2016) Yuqin Shang et al. Scientific Reports
- Amniotic fluid CA-125 as a marker of intra-amniotic inflammation associated with preterm delivery: a preliminary single center study
- (2015) Won Joon Seong ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Understanding the Unique Attributes of MUC16 (CA125): Potential Implications in Targeted Therapy
- (2015) S. Das et al. CANCER RESEARCH
- Development of a multimarker assay for differential diagnosis of benign and malignant pelvic masses
- (2015) Xinliang Chen et al. CLINICA CHIMICA ACTA
- The Ovary Is an Alternative Site of Origin for High-Grade Serous Ovarian Cancer in Mice
- (2015) Jaeyeon Kim et al. ENDOCRINOLOGY
- Clinical application of HE4 and CA125 in ovarian cancer Type I and Type II detection and differential diagnosis
- (2015) Emilia Gąsiorowska et al. Ginekologia Polska
- Why have ovarian cancer mortality rates declined? Part II. Case-fatality
- (2015) Victoria Sopik et al. GYNECOLOGIC ONCOLOGY
- Why have ovarian cancer mortality rates declined? Part III. Prospects for the future
- (2015) Victoria Sopik et al. GYNECOLOGIC ONCOLOGY
- The prognostic value of dividing epithelial ovarian cancer into type I and type II tumors based on pathologic characteristics
- (2015) Kira Philipsen Prahm et al. GYNECOLOGIC ONCOLOGY
- A novel diagnostic index combining HE4, CA125 and age may improve triage of women with suspected ovarian cancer — An international multicenter study in women with an ovarian mass
- (2015) Mona A. Karlsen et al. GYNECOLOGIC ONCOLOGY
- Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening
- (2015) Usha Menon et al. JOURNAL OF CLINICAL ONCOLOGY
- Does Aggressive Surgery Improve Outcomes? Interaction Between Preoperative Disease Burden and Complex Surgery in Patients With Advanced-Stage Ovarian Cancer: An Analysis of GOG 182
- (2015) Neil S. Horowitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Characteristics of Long-Term Survivors of Epithelial Ovarian Cancer
- (2015) Rosemary D. Cress et al. OBSTETRICS AND GYNECOLOGY
- Impact of post-laparoscopic sleeve gastrectomy weight loss on C-reactive protein, lipid profile and CA-125 in morbidly obese women
- (2015) Ghada Morshed et al. Videosurgery and Other Miniinvasive Techniques
- Relationship of tumor marker CA125 and ovarian tumor stem cells: preliminary identification
- (2015) Hui Zhang et al. Journal of Ovarian Research
- Membrane proximal ectodomain cleavage of MUC16 occurs in the acidifying Golgi/post-Golgi compartments
- (2015) Srustidhar Das et al. Scientific Reports
- Impact of post-laparoscopic sleeve gastrectomy weight loss on C-reactive protein, lipid profile and CA-125 in morbidly obese women
- (2015) Ghada Morshed et al. Videosurgery and Other Miniinvasive Techniques
- Cancer antigen 125 after delivery in women with a normal pregnancy: a prospective cohort study
- (2014) Pal B. Szecsi et al. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
- Prospects for the commercialization of chemiluminescence-based point-of-care and on-site testing devices
- (2014) Jason Y. Park et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- The new FIGO staging system for ovarian, fallopian tube, and primary peritoneal cancer
- (2014) F. Zeppernick et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Modification of Cutoff Values for HE4, CA125, the Risk of Malignancy Index, and the Risk of Malignancy Algorithm for Ovarian Cancer Detection in Jakarta, Indonesia
- (2014) Hariyono Winarto et al. Asian Pacific Journal of Cancer Prevention
- A Multiplexable, Microfluidic Platform for the Rapid Quantitation of a Biomarker Panel for Early Ovarian Cancer Detection at the Point-of-Care
- (2014) B. H. Shadfan et al. Cancer Prevention Research
- The impacts of neoadjuvant chemotherapy and of debulking surgery on survival from advanced ovarian cancer
- (2014) Barry Rosen et al. GYNECOLOGIC ONCOLOGY
- A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer
- (2014) Rudy S. Suidan et al. GYNECOLOGIC ONCOLOGY
- Costs, Effectiveness, and Workload Impact of Management Strategies for Women With an Adnexal Mass
- (2014) Laura J. Havrilesky et al. JNCI-Journal of the National Cancer Institute
- MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress
- (2014) Mildred Felder et al. Molecular Cancer
- Evaluation of human epididymis protein 4 (HE4) and Risk of Ovarian Malignancy Algorithm (ROMA) as diagnostic tools of type I and type II epithelial ovarian cancer in Japanese women
- (2014) Hiroyuki Fujiwara et al. TUMOR BIOLOGY
- Current Approaches and Challenges in Managing and Monitoring Treatment Response in Ovarian Cancer
- (2014) Charlotte S Marcus et al. Journal of Cancer
- Clinical performance of a multivariate index assay for detecting early-stage ovarian cancer
- (2013) Teresa C. Longoria et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Diagnostic performance of the biomarkers HE4 and CA125 in type I and type II epithelial ovarian cancer
- (2013) Björg Kristjansdottir et al. GYNECOLOGIC ONCOLOGY
- Ovarian Cancer
- (2013) Pascale Amate et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Clinical and Ultrasound Features of Type I and Type II Epithelial Ovarian Cancer
- (2013) Juan Luis Alcázar et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- CA-125 Level as a Prognostic Indicator in Type I and Type II Epithelial Ovarian Cancer
- (2013) Xiaoxiang Chen et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Abagovomab As Maintenance Therapy in Patients With Epithelial Ovarian Cancer: A Phase III Trial of the AGO OVAR, COGI, GINECO, and GEICO—The MIMOSA Study
- (2013) Paul Sabbatini et al. JOURNAL OF CLINICAL ONCOLOGY
- Serum human epididymis protein 4 vs carbohydrate antigen 125 for ovarian cancer diagnosis: a systematic review
- (2013) Simona Ferraro et al. JOURNAL OF CLINICAL PATHOLOGY
- CA-125–indicated asymptomatic relapse confers survival benefit to ovarian cancer patients who underwent secondary cytoreduction surgery
- (2013) Fang Wang et al. Journal of Ovarian Research
- CA-125 concentration in serum and peritoneal fluid in patients with endometriosis – preliminary results
- (2012) Maria Szubert et al. Archives of Medical Science
- Interpretation of Single and Serial Measures of HE4 and CA125 in Asymptomatic Women at High Risk for Ovarian Cancer
- (2012) N. Urban et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Diagnostic value of HE4 for ovarian cancer: a meta-analysis
- (2012) Shuang Yu et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Ovarian Cancer
- (2012) JESSICA HUNN et al. CLINICAL OBSTETRICS AND GYNECOLOGY
- The use of HE4 in the prediction of ovarian cancer in Asian women with a pelvic mass
- (2012) Karen K.L. Chan et al. GYNECOLOGIC ONCOLOGY
- Potential effect of the risk of ovarian cancer algorithm (ROCA) on the mortality outcome of the Prostate, Lung, Colorectal and Ovarian (PLCO) trial
- (2012) Paul F. Pinsky et al. INTERNATIONAL JOURNAL OF CANCER
- BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
- (2012) Kathryn Alsop et al. JOURNAL OF CLINICAL ONCOLOGY
- Longitudinal Screening Algorithm That Incorporates Change Over Time in CA125 Levels Identifies Ovarian Cancer Earlier Than a Single-Threshold Rule
- (2012) Charles W. Drescher et al. JOURNAL OF CLINICAL ONCOLOGY
- 3D microfluidic origami electrochemiluminescence immunodevice for sensitive point-of-care testing of carcinoma antigen 125
- (2012) Shaowei Wang et al. SENSORS AND ACTUATORS B-CHEMICAL
- Natural history and outcome of mucinous carcinoma of the ovary
- (2011) Maria B. Schiavone et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations
- (2011) Ritu Salani et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm
- (2011) T Van Gorp et al. BRITISH JOURNAL OF CANCER
- Recent progress in the diagnosis and treatment of ovarian cancer
- (2011) Danijela Jelovac et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A Novel Approach to Predict the Likelihood of Specific Ovarian Tumor Pathology Based on Serum CA-125: A Multicenter Observational Study
- (2011) B. Van Calster et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Large Prospective Study of Ovarian Cancer Screening in High-Risk Women: CA125 Cut-Point Defined by Menopausal Status
- (2011) S. J. Skates et al. Cancer Prevention Research
- Ovarian Cancer Biomarker Performance in Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Specimens
- (2011) D. W. Cramer et al. Cancer Prevention Research
- Serum Tumor Markers CEA, CYFRA21-1, and CA-125 Are Associated With Worse Prognosis In Advanced Non–Small-Cell Lung Cancer (NSCLC)
- (2011) Susana Cedrés et al. Clinical Lung Cancer
- Clinical significance of CA125 and CA72-4 in gastric cancer with peritoneal dissemination
- (2011) Shigenobu Emoto et al. Gastric Cancer
- Comparison of candidate serologic markers for type I and type II ovarian cancer
- (2011) Dan Lu et al. GYNECOLOGIC ONCOLOGY
- CA125 surveillance increases optimal resectability at secondary cytoreductive surgery for recurrent epithelial ovarian cancer
- (2011) Nicole D. Fleming et al. GYNECOLOGIC ONCOLOGY
- MUC16 (CA125) regulates epithelial ovarian cancer cell growth, tumorigenesis and metastasis
- (2011) Catherine Thériault et al. GYNECOLOGIC ONCOLOGY
- Longitudinal evaluation of CA-125 velocity and prediction of ovarian cancer
- (2011) Jian-Lun Xu et al. GYNECOLOGIC ONCOLOGY
- An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT)
- (2011) Dennis S. Chi et al. GYNECOLOGIC ONCOLOGY
- Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigm
- (2011) Robert J. Kurman et al. HUMAN PATHOLOGY
- Human Epididymis Protein 4 (HE4) as a Serum Tumor Biomarker in Patients With Ovarian Carcinoma
- (2011) Xiaohong Chang et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Effect of Screening on Ovarian Cancer Mortality
- (2011) Saundra S. Buys JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Potential Role of HE4 in Multimodal Screening for Epithelial Ovarian Cancer
- (2011) N. Urban et al. JNCI-Journal of the National Cancer Institute
- Long-Term Survival of Women With Epithelial Ovarian Cancer Detected by Ultrasonographic Screening
- (2011) John Rensselaer van Nagell et al. OBSTETRICS AND GYNECOLOGY
- Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass
- (2010) Richard G. Moore et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Development of an ovarian cancer screening decision model that incorporates disease heterogeneity
- (2010) Laura J. Havrilesky et al. CANCER
- CA 125 and the detection of recurrent ovarian cancer
- (2010) Robert C. Bast CANCER
- Successful Eradication of Established Peritoneal Ovarian Tumors in SCID-Beige Mice following Adoptive Transfer of T Cells Genetically Targeted to the MUC16 Antigen
- (2010) A. A. Chekmasova et al. CLINICAL CANCER RESEARCH
- Surveillance for the detection of recurrent ovarian cancer: Survival impact or lead-time bias?
- (2010) Edward J. Tanner et al. GYNECOLOGIC ONCOLOGY
- Development of a Multimarker Assay for Early Detection of Ovarian Cancer
- (2010) Zoya Yurkovetsky et al. JOURNAL OF CLINICAL ONCOLOGY
- Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial
- (2010) Gordon JS Rustin et al. LANCET
- MUC16 provides immune protection by inhibiting synapse formation between NK and ovarian tumor cells
- (2010) Jennifer AA Gubbels et al. Molecular Cancer
- Novel Monoclonal Antibodies Against the Proximal (Carboxy-Terminal) Portions of MUC16
- (2010) Thapi Dharma Rao et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials
- (2009) Andreas du Bois et al. CANCER
- Surveillance of patients after initial treatment of ovarian cancer
- (2009) Angiolo Gadducci et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer
- (2009) M. Robyn Andersen et al. GYNECOLOGIC ONCOLOGY
- Prognostic value of CA125 in advanced heart failure patients
- (2009) Sílvia Monteiro et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Assessing Lead Time of Selected Ovarian Cancer Biomarkers: A Nested Case–Control Study
- (2009) Garnet L. Anderson et al. JNCI-Journal of the National Cancer Institute
- Ovarian cancer
- (2009) Bryan T Hennessy et al. LANCET
- Screening for Ovarian Cancer
- (2009) Daniel L. Clarke-Pearson NEW ENGLAND JOURNAL OF MEDICINE
- Development and Preliminary Evaluation of a Multivariate Index Assay for Ovarian Cancer
- (2009) Suraj D. Amonkar et al. PLoS One
- The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125?
- (2008) Vladimir Nossov et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis
- (2008) Robert J. Kurman et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- CA 125, PET alone, PET–CT, CT and MRI in diagnosing recurrent ovarian carcinoma
- (2008) Ping Gu et al. EUROPEAN JOURNAL OF RADIOLOGY
- A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass
- (2008) Richard G. Moore et al. GYNECOLOGIC ONCOLOGY
- Time to stop ovarian cancer screening in BRCA1/2 mutation carriers?
- (2008) Nienke M. van der Velde et al. INTERNATIONAL JOURNAL OF CANCER
- Preoperative evaluation and triage of women with suspicious adnexal masses using risk of malignancy index
- (2008) Christopher A. Enakpene et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
- (2008) Martin Köbel et al. PLOS MEDICINE
- Structure and Function of the Cell Surface (Tethered) Mucins
- (2007) Christine L. Hattrup et al. Annual Review of Physiology
- A randomized study of screening for ovarian cancer: a multicenter study in Japan
- (2007) H. KOBAYASHI et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started